Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 77

1.

GPR18 in microglia: implications for the CNS and endocannabinoid system signalling.

McHugh D.

Br J Pharmacol. 2012 Dec;167(8):1575-82. doi: 10.1111/j.1476-5381.2012.02019.x. Review.

2.

Δ(9) -Tetrahydrocannabinol and N-arachidonyl glycine are full agonists at GPR18 receptors and induce migration in human endometrial HEC-1B cells.

McHugh D, Page J, Dunn E, Bradshaw HB.

Br J Pharmacol. 2012 Apr;165(8):2414-24. doi: 10.1111/j.1476-5381.2011.01497.x.

3.

So what do we call GPR18 now?

Alexander SP.

Br J Pharmacol. 2012 Apr;165(8):2411-3. doi: 10.1111/j.1476-5381.2011.01731.x.

4.

N-arachidonoyl glycine, an abundant endogenous lipid, potently drives directed cellular migration through GPR18, the putative abnormal cannabidiol receptor.

McHugh D, Hu SS, Rimmerman N, Juknat A, Vogel Z, Walker JM, Bradshaw HB.

BMC Neurosci. 2010 Mar 26;11:44. doi: 10.1186/1471-2202-11-44.

5.

A GPR18-based signalling system regulates IOP in murine eye.

Caldwell MD, Hu SS, Viswanathan S, Bradshaw H, Kelly ME, Straiker A.

Br J Pharmacol. 2013 Jun;169(4):834-43. doi: 10.1111/bph.12136.

6.

Parsing the players: 2-arachidonoylglycerol synthesis and degradation in the CNS.

Murataeva N, Straiker A, Mackie K.

Br J Pharmacol. 2014 Mar;171(6):1379-91. doi: 10.1111/bph.12411. Review.

7.

Novel cAMP signalling paradigms: therapeutic implications for airway disease.

Billington CK, Hall IP.

Br J Pharmacol. 2012 May;166(2):401-10. doi: 10.1111/j.1476-5381.2011.01719.x. Review.

8.

Identification of N-arachidonylglycine as the endogenous ligand for orphan G-protein-coupled receptor GPR18.

Kohno M, Hasegawa H, Inoue A, Muraoka M, Miyazaki T, Oka K, Yasukawa M.

Biochem Biophys Res Commun. 2006 Sep 1;347(3):827-32. Epub 2006 Jul 10.

PMID:
16844083
9.

Pharmacological characterization of the peripheral FAAH inhibitor URB937 in female rodents: interaction with the Abcg2 transporter in the blood-placenta barrier.

Moreno-Sanz G, Sasso O, Guijarro A, Oluyemi O, Bertorelli R, Reggiani A, Piomelli D.

Br J Pharmacol. 2012 Dec;167(8):1620-8. doi: 10.1111/j.1476-5381.2012.02098.x.

10.

The endocannabinoid anandamide protects neurons during CNS inflammation by induction of MKP-1 in microglial cells.

Eljaschewitsch E, Witting A, Mawrin C, Lee T, Schmidt PM, Wolf S, Hoertnagl H, Raine CS, Schneider-Stock R, Nitsch R, Ullrich O.

Neuron. 2006 Jan 5;49(1):67-79.

11.

Elusive equilibrium: the challenge of interpreting receptor pharmacology using calcium assays.

Charlton SJ, Vauquelin G.

Br J Pharmacol. 2010 Nov;161(6):1250-65. doi: 10.1111/j.1476-5381.2010.00863.x. Review.

12.

The background to this themed issue on neuropeptides.

Keeble J.

Br J Pharmacol. 2013 Dec;170(7):1277-8. doi: 10.1111/bph.12474.

13.

The dynamic nature of type 1 cannabinoid receptor (CB(1) ) gene transcription.

Laprairie RB, Kelly ME, Denovan-Wright EM.

Br J Pharmacol. 2012 Dec;167(8):1583-95. doi: 10.1111/j.1476-5381.2012.02175.x. Review.

14.

The serine hydrolases MAGL, ABHD6 and ABHD12 as guardians of 2-arachidonoylglycerol signalling through cannabinoid receptors.

Savinainen JR, Saario SM, Laitinen JT.

Acta Physiol (Oxf). 2012 Feb;204(2):267-76. doi: 10.1111/j.1748-1716.2011.02280.x. Epub 2011 Apr 22. Review. Erratum in: Acta Physiol (Oxf). 2012 Mar;204(3):460.

15.

A-kinase anchoring proteins as potential drug targets.

Tröger J, Moutty MC, Skroblin P, Klussmann E.

Br J Pharmacol. 2012 May;166(2):420-33. doi: 10.1111/j.1476-5381.2011.01796.x. Review.

16.

Interactions of cannabidiol with endocannabinoid signalling in hippocampal tissue.

Ryan D, Drysdale AJ, Pertwee RG, Platt B.

Eur J Neurosci. 2007 Apr;25(7):2093-102.

PMID:
17419758
17.

The neurobiology and evolution of cannabinoid signalling.

Elphick MR, Egertová M.

Philos Trans R Soc Lond B Biol Sci. 2001 Mar 29;356(1407):381-408. Review.

18.

Cultured rat microglial cells synthesize the endocannabinoid 2-arachidonylglycerol, which increases proliferation via a CB2 receptor-dependent mechanism.

Carrier EJ, Kearn CS, Barkmeier AJ, Breese NM, Yang W, Nithipatikom K, Pfister SL, Campbell WB, Hillard CJ.

Mol Pharmacol. 2004 Apr;65(4):999-1007.

19.

The endocannabinoid anandamide inhibits potassium conductance in rat cortical astrocytes.

Vignali M, Benfenati V, Caprini M, Anderova M, Nobile M, Ferroni S.

Glia. 2009 May;57(7):791-806. doi: 10.1002/glia.20807.

PMID:
19031444
20.

Modulation of neuropathic-pain-related behaviour by the spinal endocannabinoid/endovanilloid system.

Starowicz K, Przewlocka B.

Philos Trans R Soc Lond B Biol Sci. 2012 Dec 5;367(1607):3286-99. doi: 10.1098/rstb.2011.0392. Review.

Items per page

Supplemental Content

Write to the Help Desk